Compare XTNT & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XTNT | MCHX |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.7M | 61.5M |
| IPO Year | 2009 | 2003 |
| Metric | XTNT | MCHX |
|---|---|---|
| Price | $0.60 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 90.8K | 9.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.17 |
| EPS | ★ 0.03 | N/A |
| Revenue | $53,337,000.00 | ★ $90,291,000.00 |
| Revenue This Year | $15.08 | N/A |
| Revenue Next Year | N/A | $6.70 |
| P/E Ratio | $20.10 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.34 | $1.26 |
| 52 Week High | $0.95 | $2.30 |
| Indicator | XTNT | MCHX |
|---|---|---|
| Relative Strength Index (RSI) | 47.99 | 54.56 |
| Support Level | $0.55 | $1.35 |
| Resistance Level | $0.68 | $1.76 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 33.94 | 93.75 |
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.